Samjin Pharmaceuticals Co., Ltd. (KRX:005500)

Samjin Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2022	FY 2021	FY 2012	FY 2011	FY 2010
Period Ending	Jan 6, 2026	Dec 31, 2022	Dec 31, 2021	Dec 31, 2012	Dec 31, 2011	Dec 31, 2010
Market Capitalization	227,717	344,067	327,511	140,529	104,902	150,669
Market Cap Growth	1.46%	5.05%	133.05%	33.96%	-30.38%	-5.60%
Enterprise Value	-	389,035	372,478	160,616	157,311	189,264
Last Close Price	19500.00	22749.65	22613.91	7248.64	5257.09	7333.72
PE Ratio	11.29	15.72	11.53	13.21	14.85	14.38
PS Ratio	0.83	1.26	1.31	0.76	0.52	0.75
PB Ratio	0.83	1.25	1.40	1.25	0.88	1.26
P/TBV Ratio	0.86	1.30	1.46	1.27	0.89	1.28
P/FCF Ratio	-	-	-	6.60	79.58	11.66
P/OCF Ratio	13.17	19.90	13.67	4.14	8.28	8.95
EV/Sales Ratio	-	1.42	1.49	0.87	0.78	0.94
EV/EBITDA Ratio	-	11.79	9.03	7.51	5.79	7.58
EV/EBIT Ratio	-	16.78	10.98	9.28	6.58	8.57
EV/FCF Ratio	-	-	-	7.55	119.33	14.65
Debt / Equity Ratio	0.32	0.32	0.23	0.38	0.35	0.34
Debt / EBITDA Ratio	2.65	2.65	1.32	2.01	1.53	1.64
Debt / FCF Ratio	-	-	-	2.02	31.44	3.17
Asset Turnover	0.74	0.74	-	0.90	1.01	1.06
Inventory Turnover	2.26	2.26	-	3.09	3.26	3.32
Quick Ratio	0.79	0.79	1.40	1.51	1.74	2.12
Current Ratio	1.64	1.64	2.83	1.89	2.09	2.60
Return on Equity (ROE)	8.59%	8.59%	-	9.15%	5.90%	9.14%
Return on Assets (ROA)	3.92%	3.92%	-	5.25%	7.48%	7.29%
Return on Capital (ROIC)	4.45%	4.45%	-	6.83%	9.28%	8.53%
Return on Capital Employed (ROCE)	7.10%	7.10%	12.00%	13.00%	17.30%	16.10%
Earnings Yield	9.61%	6.36%	8.67%	7.57%	6.73%	6.95%
FCF Yield	-7.93%	-5.25%	-14.83%	15.14%	1.26%	8.58%
Dividend Yield	4.12%	3.52%	3.54%	-	-	0.68%
Payout Ratio	44.95%	44.95%	34.65%	26.91%	9.07%	3.56%
Buyback Yield / Dilution	2.00%	-3.00%	5.52%	0.07%	1.42%	0.02%
Total Shareholder Return	6.12%	0.52%	9.06%	0.07%	1.42%	0.70%

Updated Nov 14, 2013. Source: S&P Global Market Intelligence. Standard template. Financial Sources.